John & Marcia Goldman Foundation Donates to NIH Ebola Research

Ebola virusIn the first donation of its kind for the Foundation for the National Institutes of Health (FNIH), the John & Marcia Goldman Foundation has awarded $25,000 to support Ebola research in West Africa conducted by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health. The grant from the San Francisco-based foundation will support Ebola vaccine research by the NIAID Division of Clinical Research.
 
For more information about Ebola, including its signs and symptoms, research and statistics, please consult the following:
 
NIH: http://www.nih.gov/health/ebola.htm
 
NIAID:
http://www.niaid.nih.gov/topics/ebolaMarburg/research/Pages/default.aspx

Centers for Disease Control: http://www.cdc.gov/vhf/ebola/index.html

To donate to the FNIH for Ebola research click here >>

For the FNIH press release on the John & Marcia Goldman Foundation Donation to NIH Ebola Research click here >>
spacer

FNIH Notes

NIH, Amgen Foundation and the FNIH Announce a Collaboration to Support Undergraduate Research Opportunities

Beginning in 2015, the National Institutes of Health (NIH) will become one of a select group of institutions of higher learning taking part in the Amgen Scholars Program, which provides hundreds of summer research opportunities to undergraduate students. The program is made possible by an $850,000 grant to the Foundation for the NIH from the Amgen Foundation.
 
Read the NIH press release >>
 
Read the Amgen press
release >>

Apply to be an Amgen Scholar at the NIH >>

Donate and Support Today

NIH Clinical Center

Take Action to Support Life-Saving Medical Research
Every dollar counts! Your gift to the FNIH makes our efforts possible. With your help—and in partnership with NIH—the Foundation is advancing biomedical research and training.

Please donate generously to the Foundation for the National Institutes of Health

Charity Navigator logoDonate with Confidence
For 10 years, Charity Navigator has rated FNIH as an organization that exceeds industry standards.
spacer

News and Highlights

HABP press releaseFNIH is pleased to announce a collaboration with ICON, plc to Develop a New Patient-Reported Outcome Measure for Hospital-Acquired Bacterial Pneumonia Trials. 
More >>
spacer
ASPA 2014 NIH Arthritis Lupus AwardsThe National Institutes of Health has awarded grants to 11 research groups across the United States to establish the Accelerating Medicines Partnership in Rheumatoid Arthritis and Lupus (AMP RA/Lupus) Network. More >>

spacer

3 year study on adult Acute Lymphoblastic LeukemiaFNIH and partners from the National Cancer Institute (NCI), a component of the National Institutes of Health, NCI-designated Cancer Centers, universities, hospitals, industry partners, advocacy groups and the Food and Drug Administration, are launching a three-year initiative to determine whether minimal residual disease (MRD) can be used to predict response to therapy in adult Acute Lymphoblastic Leukemia (ALL).
More >>
spacer

AMP logoThe 2013 annual report of the Foundation for the National Institutes of Health (FNIH), New Pathways to Discovery, is now online. More >>

spacer

spacer

Click here to learn more

Key Initiatives

Biomarker Consortium logospacerBreast Cancer i-SPY 2 TrialspacerGrand Challenges in Global HealthspacerCTC VIMCspacerADNI logospacerSPIROMICS logospacerAccelerating Medicines Partnership, AMP logospacerMAL-EDspacerLung-Map logo